Navigation Links
Phoseon Technology Selected as Finalist for 2010 TechAmerica Oregon Technology Awards
Date:4/13/2010

Upcoming awards ceremony honors Oregon technology leaders.

(PRWEB) April 13, 2010 -- After building a global leadership position developing mercury-free clean energy UV-LED solutions for an array of industrial curing processes, Phoseon Technology has been selected as a Rising Star finalist for the 2010 TechAmerica Oregon Technology Awards. The award winners will be announced May 6th in Portland. Founded in 2002, Phoseon has grown through the recession and expects to accelerate sales and job growth in 2010. This acceleration is occurring as Phoseon builds on the clean energy advantage that its products offer at a similar price point as less efficient technology.

Phoseon has developed a product portfolio of clean energy UV-LED curing systems based on UV-LED technology utilizing its proprietary SLMTM (Semiconductor Light Matrix) technology that leads the world in the transition from mercury tube technology to solid state systems in many industrial applications where high intensity light – typically in the near UV spectrum - is used to dry and harden photosensitive materials. These almost “instant” UV curing and drying processes allow for accelerated production speeds, lower production costs and reduced energy usage when compared to previous curing and drying methods using heat drying or solvent evaporation.

In addition to being mercury-free, Phoseon’s clean energy lamps typically offer a 50 percent energy savings to customers transitioning from traditional mercury UV lamp systems. Other benefits include longer life, high performance, lower operating costs, complete elimination of ozone production in the workplace and elimination of exposure to the more dangerous lower UV wavelengths for workers.

Phoseon is increasingly reaching out to sustainability managers in large companies to generate awareness of the environmental advantages of its prod
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Phoseon Technology Continues Worldwide Rollout of UV-LED Curing Systems with Attendance at Printing South China 2010
2. Agfa Turns to Phoseon Technology for its First Application of UV-LED Curing on the :Anapurna Wide Format UV Inkjet Printers
3. Strategic Connections Ranks 90th Fastest-Growing Technology Company in North America and 14th in Canada
4. CapSite™ Provides Detailed Transparency on Healthcare Technology Purchases
5. Pollogen Launches the Maximus, Advanced Solution for Fat Reduction and Body Shaping based on Innovative TriLipo Technology
6. UTHealth receives $15 million for health information technology research
7. UTHealth to serve as Health Information Technology Regional Extension Center
8. Want better health information technology? Ask patients how they want it
9. Intellidimension Announces Semantic Web Technology Partnership with Matrikon
10. IVR Technology Group Announces iCANsm Services
11. Startup to develop new solid-state technology at UCLA for use in medical imaging
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Phoseon Technology Selected as Finalist for 2010 TechAmerica Oregon Technology Awards  
(Date:5/23/2013)... May 23, 2013 Footwear etc. is pleased ... Vista Collection of sandals containing cork footbeds. Known for its ... consistently good sales for many years, and with this new ... summer. , Dansko Shoes and Sandals are ... Collection is no exception. Containing leather and patent leather uppers ...
(Date:5/23/2013)... May 23, 2013 Following the recent ... UK internet users, the security team at idcloak Technologies ... safeguards against this or any web-born malware. Gill-Chris ... technology provides far better privacy and security ... underlined that even the best AV software cannot be ...
(Date:5/23/2013)... 2013 Long-Term Care Insurance shopping ... rate at which applicants for Long Term Care Insurance are ... , The decision to buy a Long Term Care ... willing and able to purchase protection are increasingly being turned ... any price. A variety of chronic conditions appear to ...
(Date:5/23/2013)... 2013 When Teachers Notebook reached out ... raise funds for the Moore, OK tornado victims, they ... items that could be sold for around $10.00 with ... at Teachers Notebook were overwhelmed by the response from ... of materials within the first 12 hours of the ...
(Date:5/23/2013)... 2013 AttorneyOne.com, a recognized authority on ... actively providing expert opinion in view of the recent ... According to court documents, on March 5, 2013 a ... (case no. 3:2013cv50102) alleging that her husband suffered massive ... Pharmaceuticals, is mainly used as a blood thinner for ...
Breaking Medicine News(10 mins):Health News:Footwear etc. Announces the New Collection of Dansko Cork Sandals 2Health News:Effective virus protection without anti-virus software, identifies idcloak 2Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 2Health News:More Baby Boomers Rejected by Long Term Care Insurance Companies 3Health News:Teachers Rally to Raise Funds for Moore Tornado Victims 2Health News:New Lawsuit on Pradaxa Brain Hemorrhage: Now, AttorneyOne Can Provide Advice 2
... ... chairman of the board of directors for PerfectServe, a clinical communications company currently serving ... ... Gene Barduson was recently named executive chairman of the board of directors for ...
... , , BOCA RATON, ... the market leader in all-natural herbal and homeopathic remedies for ... as their PR firm of record. The company,s two brands, ... provide complete lines of safe, scientifically-tested, guaranteed products that promote ...
... AllegroMedical.com partners with ... ... help find a cure for spinal cord injury: The online retailer of medical supplies ... is a forward-thinking manufacturer of catheters. In an effort to facilitate finding a cure ...
... more emotional and behavioral difficulties when compared to other ... most when a parent is deployed overseas, according to ... having a parent deployed for a longer period of ... with emotional problems were important factors associated with whether ...
... , , Consumers ... SILVER SPRING, Md., Dec. 6 The U.S. Food and Drug ... San Antonio Bay on or after Nov. 16 due to reports ... from this area, which is located on the Gulf of Texas. ...
... College of Wisconsin, in Milwaukee, found a substantial variation ... disease complications in children. Barriers to its use on ... identified. The study led by Amanda M. Brandow, ... College and Children,s Research Institute at the Children,s Hospital ...
Cached Medicine News:Health News:Gene Barduson Named Chairman of PerfectServe Board of Directors 2Health News:Native Remedies and PetAlive.com Hires TransMedia Group to Herald Herbal for People and Pets 2Health News:Online Medical Supply Superstore Adds Cure Catheters to Product Mix 2Health News:Military children face more emotional challenges as parental deployments grow longer, study finds 2Health News:Military children face more emotional challenges as parental deployments grow longer, study finds 3Health News:FDA, CDC, and States Investigating Norovirus Illnesses Linked to Oysters 2Health News:New study finds barriers to pain treatment in children with sickle cell disease 2
(Date:5/22/2013)... , May 22, 2013 The new 13-valent ... as the previous version used prior to 2010, the ... Permanente study published today in Vaccine. The ... beginning in 2010 after a series of trials. These ... range of pneumococcal types than the previously used PCV7, ...
(Date:5/22/2013)... YORK , May 22, 2013 ... LLP is investigating claims on behalf of investors of ... ISRG ) (CUSIP: 46120E602) who purchased Intuitive ... 18, 2013 (the "Class Period"). Such investors are advised ... at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ...
(Date:5/22/2013)... May 22, 2013 Hemoglobin A1C levels ... with Type 2 diabetes, while modest improvements in ... outcomes and can lead to substantial healthcare cost ... International Society for Pharmacoeconomics and Outcomes Research (ISPOR) ... studies, sponsored by Valeritas, makers of the V-Go ...
Breaking Medicine Technology:Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 2Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 3Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 4SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6
... , , ... OPTR ) today announced that new data highlighting ... vancomycin-resistant enterococci (VRE) acquisition from Optimer,s North American phase 3 ... Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco. , ...
... HONG KONG, Sept. 15 Data from multiple clinical trials ... stent, and preclinical data from Combo Bio-engineered Sirolimus Eluting Stent ... symposium, TCT 2009, in San Francisco. , , ... Center in Amsterdam will provide the final 12-month outcomes from ...
Cached Medicine Technology:Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI) 2Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI) 3Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI) 4Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI) 5Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI) 6Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2009 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2009 3
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: